Thought Leadership for Life Science Leaders

Blog

Speak to Our Thought Leaders Today

FDA Inspection Results & Quality Outcome: Lack of Connection

watermelon quality

After decades in the pharma, device, and biologics industry working in new product development and manufacturing quality; market quality and post market surveillance; and quality systems my answer can be summed up in one word. Watermelon. yes, watermelon.

Why watermelon? Today’s drive to measure, measure, measure has yielded a culture of creating metrics that will be green. As green as the exterior of a ripe watermelon. Why? Measures and metrics are tied to performance which is tied to compensation, bonus, recognition and reward. But what color is the interior of the watermelon? Red.

Often the processes and outputs existing under the top line metrics are red, red, red. In some companies these “sub measures” have been created, monitored and reported. In some companies they are not.

fda inspections and quality

Predictive Measures

The challenge in our industry is to create robust quality measures that are predictive and that monitor the quality of how we execute our key processes in clinical and product development, production and distribution. We must look for the reds and see them as sweet… just like the inside of the watermelon! Taken seriously those metrics will drive true improvement.

Contact Us

To learn more about this lack of connection, contact us by filling out the form below.

Advancing Clinical Investigator Site Audits: A Quality-Focused, Risk-Based Approach

Clinical research is undergoing a profound transformation, driven by technological innovation, globalization, evolving...

Learning from Recent FDA Warning Letters: A Call for Proactive Compliance

Every FDA Warning Letter offers more than a glimpse into individual noncompliance; it...

Informed consent is one of the most vital elements of ethical clinical research....